Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,328,000
+$4,949,600 QoQ
Shares Held
1,840,000
0.0% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $705,487,766 across 26 Biotechnology names. DNLI ranks #4 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $250,645,634 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
14,418,574 | $143,464,811 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $56,635,000 | |
| 4 | DNLI |
Denali Therapeutics Inc.
This page
|
1,840,000 | $35,328,000 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $32,170,500 | |
| 6 | NGNE |
Neurogene Inc.
|
1,420,361 | $28,634,477 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,000 | $24,815,250 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
758,857 | $22,651,881 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,328,000 | 1,840,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,378,400 | 1,840,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,922,800 | 890,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,451,100 | 890,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,459,050 | 990,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,176,200 | 990,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,838,700 | 990,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,186,000 | 1,300,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $26,676,000 | 1,300,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,898,000 | 1,300,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,819,000 | 1,300,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,363,000 | 1,300,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $29,952,000 | 1,300,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,153,000 | 1,300,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $30,536,550 | 995,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $44,145,000 | 1,500,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $48,255,000 | 1,500,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,900,000 | 1,500,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $85,765,000 | 1,700,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $126,288,400 | 1,610,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $91,931,000 | 1,610,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $109,725,600 | 1,310,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $46,937,300 | 1,310,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $31,675,800 | 1,310,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $25,477,050 | 1,455,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||